Importing Retatrutide to Australia
Retatrutide is not approved by the Therapeutic Goods Administration. Australian Border Force applies strict controls on imported medicines, and shipments of unapproved peptides are frequently seized. The Personal Importation Scheme allows individuals to import up to three months supply of an unapproved medicine for personal use, but this requires a prescription from an Australian doctor and the drug must be for a serious condition. Grey market research peptide vendors operate in Australia but face legal risks under the Therapeutic Goods Act. Buyers should understand these risks before ordering.
Australian Pricing and Availability
Australian research chemical vendors typically price retatrutide at AUD -200 for a 10 mg vial, reflecting the smaller market and higher shipping costs. Some vendors accept cryptocurrency payments and ship within Australia to avoid customs. The grey market for GLP-1 research peptides in Australia has grown significantly since the Ozempic shortage of 2023-2024, and retatrutide availability follows that trend. Private compounding pharmacies in Australia may offer compounded GLP-1 products, but retatrutide is unlikely to be available through this channel until after TGA approval.
Leave a Reply